Biotechnology

A recent breakthrough in DNA synthesis has significantly reduced the time it takes to build new genetic sequences, according to a report in IEEE Spectrum. This advancement could have major implications for fields such as biotechnology and synthetic biology.

The CEOs of several major AI companies, including OpenAI's Sam Altman and Anthropic's Dario Amodei, have signed an open letter urging Congress to adopt laws requiring companies to screen customers and orders for synthetic DNA and RNA to prevent bioweapon misuse.